Apontis Pharma AG (XTER:APPH) EV-to-FCF : -7.47 (As of Mar. 28, 2025)

Apontis Pharma AG EV-to-FCF Chart

Apontis Pharma AG Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-FCF	Get a 7-Day Free Trial					-	4.13	-	-1.20	-

Competitive Comparison of Apontis Pharma AG's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Apontis Pharma AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apontis Pharma AG's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apontis Pharma AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Apontis Pharma AG's EV-to-FCF falls into.

Apontis Pharma AG EV-to-FCF Calculation

Apontis Pharma AG's EV-to-FCF for today is calculated as:

Apontis Pharma AG's current Enterprise Value is €75.64 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apontis Pharma AG's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-10.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apontis Pharma AG  (XTER:APPH) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Apontis Pharma AG's PE Ratio (TTM) for today is calculated as:

Apontis Pharma AG's share price for today is €11.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apontis Pharma AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.832.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Apontis Pharma AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Apontis Pharma AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Apontis Pharma AG Business Description